Trademark News for 27-May-2009
- 'Advaxis Receives US Patent and Trademark Office Approval on Act-A Protein Patent-Pending Rights (Business Wire via Yahoo! Finance)
NORTH BRUNSWICK, N.J.----The US Patent and trademark office approved Advaxis Incorporated patent-application Compositions and Methods for Enhancing the Immunogenicity of Antigens . This patent application covers the use of Listeria monocytogenes protein ActA and fragments of this protein for use in the creation of antigen fusion proteins.
'Facebook Trademark Dispute Resolved (WebProNews)
Another argument regarding Facebook's origins seems to have been cleared up. Think Computer Corporation and Facebook reached a private settlement late last week, ending a dispute that concerned nothing less than the name of the well-known social network. Aaron Greenspan, founder and CEO of Think Computer Corporation, attended Harvard with Facebook cofounder Mark Zuckerberg. Greenspan also ...
'How To Protect Your Brand Under Google?s New Trademark Policies (Search Engine Land)
If you are a Google Adwords customer you may have read that the Adwords? trademark enforcement policies are going through a big change which will impact the control that you have over use of your brands on paid search. The new policies will impact you starting on June 4 th and June 15 th , 2009.
'Cartier Sues Apple for Trademark Infringement (PC World)
French jeweler and watchmaker Cartier sued Apple on Friday for infringing on its trademark, according to The Associated Press, Dow Jones, and others.
'Cannasat Therapeutics Announces Favourable Decision From United States Patent and Trademark Office (Marketwire)
TORONTO, ONTARIO--(Marketwire - May 25, 2009) - Cannasat Therapeutics (TSX VENTURE:CTH) ("Cannasat" or the "Company") is pleased to announce today that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a U.S. Patent Application which forms the basis for Cannasat's lead product, Relivar. Cannasat is the exclusive licensee of the patent application. It is ...
'ALDA Receives Approval of "T36 Disinfex" Trademark (Marketwire)
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 26, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") has received a Notice of Allowance from the Canadian Intellectual Property Office for the trademark "T36 Disinfex". On filing of an executed Declaration of Use and payment of the prescribed registration fee, the trademark will proceed to registration. Dr. ...
Return to Trademark Lawyer :: Cristi Trusler, Attorney
Return to Trademark News Archive
